Skip to main content

Volume 2 Supplement 2

Proceedings of the Experts Meeting on Lung Cancer and the Use of Erlotinib

Proceedings

Edited by Aldo Castagnari

Publication of this supplement was supported by Laboratorios Roche Syntex México

Experts Meeting on Lung Cancer and the Use of Erlotinib.

New York, USA10 November 2007

Annual Journal Metrics

  • Speed
    40 days from acceptance to publication

    Citation Impact
    3.100 - Cite Score
    0.693 - Source Normalized Impact per Paper (SNIP)
    0.790 - SCImago Journal Rank (SJR)

    Usage
    468,191 downloads
    53 Altmetric mentions